$1.86M OptumRx unsolicited calls class action settlement

OptumRx agreed to pay $1.86 million to resolve claims it violated the federal Telephone Consumer Protection Act (TCPA) with unsolicited phone calls.

The OptumRx settlement benefits individuals who received clinical adherence calls from OptumRx that used an artificial or prerecorded voice since April 20, 2020. These calls do not include prescription refill reminders or calls regarding COVID-19 vaccines.

OptumRx is a pharmacy care service that helps consumers manage their medications and prescriptions. The company is part of the larger Optum health services company.

According to a class action lawsuit, OptumRx violated the TCPA by placing unsolicited phone calls to consumers. Plaintiffs in the case say they never gave OptumRx their consent to contact them in this manner.

The TCPA prohibits telemarketers from contacting consumers without their express written consent. The law also requires telemarketers to provide an opt-out option for consumers who do not wish to be contacted.

OptumRx has not admitted any wrongdoing but agreed to a $1.86 million class action settlement to resolve the allegations.

Under the terms of the OptumRx TCPA violation settlement, class members can receive an equal share of the net settlement fund. Class members are estimated to receive between $72 and $135, but exact payments will vary depending on the number of claims filed with the settlement.

The deadline for exclusion and objection is Feb. 4, 2026.

The final approval hearing for the OptumRx settlement is scheduled for March 31, 2026.

To receive settlement benefits, class members must submit a valid claim form by Feb. 4, 2026.

Who’s Eligible

The settlement benefits individuals who are not OptumRx customers or account holders who received a clinical adherence call from OptumRx between April 20, 2020, and Oct. 22, 2025, that was directed to a number assigned to a cellular telephone or VOIP service and that used an artificial or prerecorded voice.

Potential Award

Between $72 and $135, depending on the number of claims submitted.

Proof of Purchase

Telephone number that received the calls.

Claim Form

NOTE: If you do not qualify for this settlement do NOT file a claim.

Remember: you are submitting your claim under penalty of perjury. You are also harming other eligible Class Members by submitting a fraudulent claim. If you’re unsure if you qualify, please read the FAQ section of the Settlement Administrator’s website to ensure you meet all standards (Top Class Actions is not a Settlement Administrator). If you don’t qualify for this settlement, check out our database of other open class action settlements you may be eligible for.

Claim Form Deadline

02/04/2026

Case Name

Patterson v. OptumRx Inc., Case No. 1:24-cv-00689-TWP-KMB, in the U.S. District Court for the Southern District of Indiana

Final Hearing

03/31/2026

Settlement Website

OptumRxTCPAClassActionSettlement.com

Claims Administrator

Patterson v. OptumRx Inc.
c/o Kroll Settlement Administration LLC
P.O. Box 225391
New York, NY 10150-5391
833-630-5368

Class Counsel

James L. Davidson
GREENWALD DAVIDSON RADBIL PLLC

Defense Counsel

Carolyn A. DeLone
HOGAN LOVELLS US LLP